ATLANTA--(EON: Enhanced Online News)--The Bio/Med Investor Network (BioMed) today announced the hiring of its first Managing Director, Stephen MacDonald, Ph.D. In this role, he oversees network-wide projects ranging from planning and executing numerous events, marketing campaigns, and coordinating all logistics for the network and its members.
“As BioMed continues to grow in this very technical and complex life science and medical arena, Stephen’s patent agent background in medical innovation and the sciences will be invaluable to our organization”
A long-time member of the Georgia life sciences community, Dr. MacDonald came to Atlanta in 2000 for a post-doctoral fellowship at Emory University. He has spent most of his career as a registered patent agent and patent consultant with 15 years of experience in the life sciences sector. His experience includes evaluating and prosecuting early stage intellectual property and advising small to large sized companies on patent prosecution, due diligence and commercialization strategy. He also serves as Vice President of Member Relations for Georgia Bio, the state’s life science industry association. His unique background speaking the languages of science, business and law, positions him to engage with Georgia’s life sciences industry and be a highly effective leader of the Bio/Med Investor Network.
“As BioMed continues to grow in this very technical and complex life science and medical arena, Stephen’s patent agent background in medical innovation and the sciences will be invaluable to our organization,” said Bob McNally, Executive Committee member and CEO of GeoVax Labs.
Dr. MacDonald was an original founder of Georgia Bio’s Emerging Leaders Network and was awarded Georgia Bio’s Emerging Leader of the Year award in 2008. He has chaired the Southeast BIO sponsorship committee since 2014, and has been a board trustee of the Ron Clark Academy and chair of their Board governance subcommittee since 2011.
“We are pleased to have Stephen on board with BioMed,” said Frank McDaniel, Chair of the BioMed Board of Directors. “It takes only moments into a conversation with him to be caught up in his infectious enthusiasm for our biosciences community, and his deep understanding for both the art and business of the science.”
Dr. MacDonald received his Ph.D. in neuroscience from the University of Manitoba, and conducted post-doctoral research at Emory University School of Medicine. He has an MBA from Georgia State University’s Robinson College of Business.
About Bio/Med Investor Network
The Bio/Med Investor Network was formed in 2014 to address the need for funding in early-stage bioscience and healthcare companies. Network members are accredited angel investors specializing in these fields to provide a high level of scrutiny and guidance for growing companies. The Network is based in Atlanta, Georgia with about 50 investor/members. More information can be found at www.biomedinvestors.com.